Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RARA | P10276 | 12/20 | 0.37 |
| ▸ | RARB | P10826 | 12/20 | 0.37 |
| ▸ | RARG | P13631 | 12/20 | 0.37 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.37 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.34 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10557217 | 0.88 | RARA (0.45) | RXRARXRBRARARARBRARG | |
| SCHEMBL7715340 | 0.82 | RXRA (0.35) | RXRARXRBRARARARBRARG | |
| SCHEMBL7713122 | 0.78 | RARA (0.36) | RXRARARARARBRARGCYP3A4 | |
| Bromide SCHEMBL9144066 | 0.76 | RARA (0.33) | RXRARXRBRARARARBRARG | |
| SCHEMBL6610666 | 0.76 | PTGS1 (0.34) | RXRARXRBRARARARBRARG | |
| SCHEMBL3541162 | 0.76 | RXRA (0.58) | RXRARXRBRARARARBRARG | |
| SCHEMBL6668874 | 0.75 | EPHX2 (0.39) | RXRARARARARBRARGCYP3A4 | |
| SCHEMBL12715250 | 0.74 | RARA (0.44) | RXRARXRBRARARARBRARG | |
| SCHEMBL4843112 | 0.74 | PTGS1 (0.35) | RXRARARARARBRARGCYP3A4 | |
| SCHEMBL19259616 | 0.73 | RARA (0.37) | RXRARARARARBRARGCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0350846-B1 | Condensed heterocyclic compounds and their use in therapy | HOFFMANN LA ROCHE (CH) | 1995-10-11 | — | — | EP | disclosed |
| US-5420273-A | Skin disorders and antitumor agents | HOFFMAN-LA ROCHE INC. (US) | 1995-05-30 | — | — | US | disclosed |
| US-5300522-A | Treating inflammatory, allergic, rheumatic, immunological disorders | HOFFMANN-LA ROCHE INC. (US) | 1994-04-05 | — | — | US | disclosed |
| US-5164387-A | Antitumor agents, skin disorders, antiinflammatory agents | HOFFMANN-LAROCHE INC. (US) | 1992-11-17 | — | — | US | disclosed |
| US-5037825-A | Useful In The Treatment Of Neoplasms, Dermatoses And Aging Of The Skin | HOFFMANN-LA ROCHE INC. (US) | 1991-08-06 | — | — | US | disclosed |
| EP-0350846-A2 | Condensed heterocyclic compounds and their use in therapy | F. HOFFMANN-LA ROCHE AG (CH) | 1990-01-17 | — | — | EP | disclosed |